Shannon Higgins-gruber

Title: Shannon Higgins-Gruber: Innovator in Pharmaceutical Compositions

Introduction

Shannon Higgins-Gruber is a notable inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that have potential therapeutic applications.

Latest Patents

Shannon holds a patent for pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile. This patent outlines methods of using these compositions, which include oral dosage formulations. The invention provides a detailed description of the pharmaceutical compositions, including various forms such as enantiomers, mixtures of enantiomers, tautomers, isotopologs, or pharmaceutically acceptable salts, along with a carrier or diluent.

Career Highlights

Shannon is currently associated with Celgene Corporation, a leading biopharmaceutical company known for its innovative therapies. His work at Celgene has allowed him to focus on developing groundbreaking pharmaceutical solutions that address critical health challenges.

Collaborations

Shannon has collaborated with several talented individuals in his field, including Anjali Agrawal and Biplob K Mitra. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Shannon Higgins-Gruber's contributions to pharmaceutical compositions exemplify the innovative spirit of modern inventors. His work continues to impact the field positively, paving the way for future advancements in medicine.